VEEV— AI Stock Forecast & Price Targets

Revenue trajectory is steady and accelerating modestly: quarterly revenue progressed from $759M (Apr-25) to $789M, $811M, and $836M (Jan-26), a ~10% YoY run-rate, with TTM revenue of $3.20B. Profitability is exceptional for a software company: gross margin 74-77%, operating margin recently 29.4%, and net margin ~29% — Q1 FY27 net income of $244M shows operating leverage is intact. The balance sheet is a standout: $6.56B total cash vs. only $95.9M total debt, current ratio 4.89, and working capital of $6.36B, giving enormous optionality for M&A or buybacks. Free cash flow is lumpy on a quarterly basis ($877M in Apr-25 reflecting billing seasonality, then $238M/$193M/$107M) but TTM FCF of $1.05B on $3.20B revenue is a ~33% FCF margin — best-in-class. ROE of 13.9% is modest only because of the cash drag; ex-cash returns on operating capital are far higher. Debt-to-equity of 1.33 reported by the data source looks inconsistent with the underlying balance sheet ($1.76B liabilities vs. $7.21B equity = ~0.24x); even taking the higher figure, leverage is not a concern. Nothing material appears broken; the question is purely growth durability and multiple.

Across timeframes the picture is mixed-to-constructive. The 1wk chart shows the stock cut roughly in half from $340 highs to a recent low near $160, with price now reclaiming $178 — a long basing process, and the Kronos weekly forecast points up toward ~$240 with a wide band. The 1d forecast is more aggressive, projecting an initial spike toward $260 before fading to $214 — note the forecast band is wide and the actual is still well below the lower band, suggesting the model may be over-extrapolating the post-earnings move. The 4h forecast cleanly tracks higher to $251, while the 1h is the most ambiguous, sitting just under $181 forecast vs. $178.69 actual after a rejection from ~$190. Key support sits at $160 (recent multi-test low) and $148 (52w low); resistance is layered at $190 (recent swing high), $215, and $240 (the gravity zone in multiple forecasts). Directional accuracy of the 1d model is 67.9% over 30 days but MAPE is ~22.8% and MAE is $40 — i.e., the forecasts have been directionally useful but magnitude-wise too optimistic, which is a real caveat. Near-term bullish probability of 0.40 (vs. composite 1.0) flags that the immediate setup is less convincing than the structural one.

• Veeva Falcon AI launch (announced June 4, 2026) targeting drug development — first material AI monetization vector for the company
• Vault CRM migration from legacy Salesforce-based CRM — multi-year tailwind explicitly called out as gaining traction in Q1 FY27 commentary
• Veeva Data Cloud (OpenData, Link, Compass, CRM Pulse) expanding into de-identified patient data — adjacent TAM beyond core software
• Raised FY27 outlook signals management visibility into accelerating bookings
• $6.56B net cash position enables tuck-in AI/data acquisitions without dilution

• Stock down ~42% from 52w high of $310.50 to $178.72 — trend damage suggests the market is questioning growth durability or multiple
• Trailing PE of 31.6x is still premium for ~10% revenue growth; further multiple compression possible in a risk-off tape
• Kronos 1d model MAPE of 22.8% and MAE of $40 indicates forecasts have been systematically too optimistic — discount the bullish targets accordingly
• Near-term bullish probability of only 0.40 despite composite 1.0 — short-term setup is weaker than the structural one
• Vault CRM migration execution risk vs. Salesforce; any large customer defection would be a thesis-breaker
• AI hype cycle risk — Falcon must show real revenue, not just narrative, within 2-4 quarters
• Broader software de-rating: AI-driven tech layoffs at highest since 2023 (per market news) signals sector pressure